Efficacy in Sudden Sensorineural Hearing Loss Demonstrated in Double-Blind RCT; Academic Verification of In-Body Explosion Risk from High-Concentration Hydrogen Inhalation

AI Summary (NQ-processed)

MiZ Company Limited and Ehime University have published research demonstrating the efficacy of low-concentration hydrogen inhalation for treating sudden sensorineural hearing loss, while also highlighting the severe in-body explosion risks associated with high-concentration hydrogen inhalers. The company strongly advocates for a shift to safe, low-concentration hydrogen therapies to ensure patient safety and effectively manage oxidative stress.